Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHA:603882)
China · Delayed Price · Currency is CNY 27.31
-0.89 (-3.16%)
Apr 28, 2026, 3:00 PM CST
SHA:603882 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -108.03 | -178.6 | -381.24 | 643.38 | 2,755 | 2,220 |
Depreciation & Amortization | 414.45 | 414.45 | 547.6 | 571 | 528.4 | 425.98 |
Other Amortization | 88.26 | 88.26 | 104.82 | 107.57 | 90.46 | 107.99 |
Loss (Gain) From Sale of Assets | -4.4 | -4.4 | -6.36 | -2.2 | -3.99 | 9.74 |
Asset Writedown & Restructuring Costs | 16.16 | 16.16 | 149.96 | 9.77 | 1.02 | 0.37 |
Loss (Gain) From Sale of Investments | -3.84 | -3.84 | 140.82 | -262.97 | 10.8 | 7.29 |
Provision & Write-off of Bad Debts | - | - | 618.94 | 488.41 | 255.31 | 71.09 |
Other Operating Activities | 303.51 | 385.16 | -15.02 | 14.13 | 105.32 | 172.8 |
Change in Accounts Receivable | 742.6 | 742.6 | 263.52 | 1,247 | -2,702 | -2,116 |
Change in Inventory | 12.21 | 12.21 | 49.89 | 157.42 | -58.82 | -107.02 |
Change in Accounts Payable | -193.55 | -193.55 | -413.54 | -1,633 | 891.85 | 1,162 |
Change in Other Net Operating Assets | - | - | -33.19 | -40.89 | 102.14 | 133.14 |
Operating Cash Flow | 1,191 | 1,202 | 906.35 | 1,231 | 1,948 | 2,088 |
Operating Cash Flow Growth | 8.35% | 32.62% | -26.36% | -36.81% | -6.71% | 37.09% |
Capital Expenditures | -425.24 | -423.46 | -446.36 | -714.75 | -840.54 | -952.42 |
Sale of Property, Plant & Equipment | 20.69 | 19.63 | 15.2 | 18.94 | 20.37 | 73.23 |
Cash Acquisitions | - | - | - | -6.7 | -22.09 | - |
Divestitures | - | - | - | 218.03 | - | - |
Investment in Securities | -19.99 | 21.72 | -25.88 | -150.29 | -8.52 | -131.98 |
Other Investing Activities | 14.66 | 11.13 | 1.51 | 0.23 | 2.41 | 1.55 |
Investing Cash Flow | -409.87 | -370.97 | -455.53 | -634.53 | -848.37 | -1,010 |
Long-Term Debt Issued | - | 221.89 | 368.84 | 206.26 | 80 | - |
Long-Term Debt Repaid | - | -87.49 | -219.76 | -330.43 | -295.51 | -187.63 |
Net Debt Issued (Repaid) | 120.85 | 134.4 | 149.08 | -124.16 | -215.51 | -187.63 |
Issuance of Common Stock | - | - | - | 41.76 | 36.63 | 342.13 |
Repurchase of Common Stock | - | - | -210 | -89.99 | - | - |
Common Dividends Paid | -414.94 | -413.9 | -419.57 | -839.33 | -609.52 | -169.98 |
Other Financing Activities | -109.55 | -114.7 | -8.31 | -50.29 | -80.17 | -37.54 |
Financing Cash Flow | -403.63 | -394.2 | -488.8 | -1,062 | -868.57 | -53.03 |
Foreign Exchange Rate Adjustments | -0.92 | -13.55 | 10.83 | 7.39 | 38.95 | -11.46 |
Net Cash Flow | 376.5 | 423.28 | -27.15 | -458.34 | 269.86 | 1,014 |
Free Cash Flow | 765.7 | 778.55 | 459.99 | 516.07 | 1,107 | 1,136 |
Free Cash Flow Growth | 19.03% | 69.26% | -10.87% | -53.39% | -2.49% | 16.77% |
Free Cash Flow Margin | 12.95% | 12.91% | 6.40% | 6.04% | 7.16% | 9.51% |
Free Cash Flow Per Share | 1.63 | 1.66 | 0.99 | 1.11 | 2.37 | 2.44 |
Cash Income Tax Paid | 72.44 | 79.71 | 182.67 | 392.94 | 587.14 | 294.69 |
Levered Free Cash Flow | 1,002 | 1,111 | 530.61 | 292.07 | 284.4 | 502.44 |
Unlevered Free Cash Flow | 1,002 | 1,111 | 542.13 | 304.82 | 299.18 | 519.66 |
Change in Working Capital | 484.82 | 484.82 | -253.18 | -338.27 | -1,794 | -926.93 |
Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.